Literature DB >> 20349070

Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

Hasan Ulusoy1.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare but extremely disabling genetic disease of the skeletal system. This disease is characterized by progression of heterotopic ossification within skeletal muscles, ligaments and tendons. Most patients with FOP are misdiagnosed early in life before the appearance of heterotopic ossification and undergo diagnostic procedures such as biopsy that can cause lifelong disability. Almost all of the patients have some peculiar congenital anomalies, including short great toes, hallux valgus, short thumbs and hypoplasia of digital phalanges. These congenital defects support the diagnosis of FOP, but are not constantly observed in the totality of patients. If necessary, genetic studies can be performed to confirm the diagnosis. Once diagnosed, patients should be advised in order to avoid unnecessary traumas, surgical procedures, biopsies, intramuscular injections and vaccinations. Here, we describe a patient with FOP without characteristic congenital skeletal anomalies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349070     DOI: 10.1007/s00296-010-1426-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva.

Authors:  W G Kussmaul; A N Esmail; Y Sagar; J Ross; S Gregory; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1998-01       Impact factor: 4.176

2.  The hand and foot malformations in fibrodysplasia ossificans progressiva.

Authors:  H W Schroeder; M Zasloff
Journal:  Johns Hopkins Med J       Date:  1980-08

3.  Fibrodysplasia ossificans progressiva.

Authors:  S Mahboubi; D L Glaser; E M Shore; F S Kaplan
Journal:  Pediatr Radiol       Date:  2001-05

4.  Limb swelling in patients who have fibrodysplasia ossificans progressiva.

Authors:  J M Moriatis; F H Gannon; E M Shore; W Bilker; M A Zasloff; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1997-03       Impact factor: 4.176

5.  Fibrodysplasia ossificans progressiva. A survey of forty-two cases.

Authors:  J G Rogers; W B Geho
Journal:  J Bone Joint Surg Am       Date:  1979-09       Impact factor: 5.284

6.  A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).

Authors:  Hirokazu Furuya; Koji Ikezoe; Lixiang Wang; Yasumasa Ohyagi; Kyoko Motomura; Naoki Fujii; Jun-Ichi Kira; Yasuyuki Fukumaki
Journal:  Am J Med Genet A       Date:  2008-02-15       Impact factor: 2.802

7.  Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.

Authors:  J M Connor; D A Evans
Journal:  J Bone Joint Surg Br       Date:  1982

Review 8.  Congenital platelike osteoma cutis: case report and review of the literature.

Authors:  O Sanmartín; V Alegre; A Martinez-Aparicio; R Botella-Estrada; A Aliaga
Journal:  Pediatr Dermatol       Date:  1993-06       Impact factor: 1.588

Review 9.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

10.  [A perspective on the control of myositis ossificans progressiva]

Authors:  D B Palhares; L M Leme
Journal:  J Pediatr (Rio J)       Date:  2001 Sep-Oct       Impact factor: 2.197

View more
  5 in total

1.  Is fibrodysplasia ossificans progressiva ever seen without skeletal abnormalities?

Authors:  Sumeet Gulshan Dua; Nilendu C Purandare
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

2.  Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.

Authors:  Masato Yano; Naoyuki Kawao; Katsumi Okumoto; Yukinori Tamura; Kiyotaka Okada; Hiroshi Kaji
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

3.  Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.

Authors:  Naoyuki Kawao; Masato Yano; Yukinori Tamura; Katsumi Okumoto; Kiyotaka Okada; Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2015-07-24       Impact factor: 2.626

Review 4.  Challenges in the treatment of fibrodysplasia ossificans progressiva.

Authors:  Kardelen Gencer-Atalay; Ekim Can Ozturk; Ilker Yagci; Pinar Ata; Kenan Delil; Zerrin Ozgen; Gulseren Akyuz
Journal:  Rheumatol Int       Date:  2018-10-20       Impact factor: 2.631

5.  Myositis Ossificans Presenting as a Rapidly Enlarging Neck Mass With Dyspnea.

Authors:  Haley Hullfish; Christie McGee; Luiz Paulo De Lima Guido; Elizabeth Nicolli
Journal:  OTO Open       Date:  2022-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.